한글목차

망막장애 치료 시장 규모는 최근 몇 년간 크게 성장했습니다. 2025년 136억 9,000만 달러에서 2026년에는 148억 6,000만 달러에 이르고, CAGR 8.6%의 성장이 전망되고 있습니다. 지난 수년간의 성장에는 노인황반변성 유병률 증가, 전 세계 당뇨병 환자 증가, 안과 클리닉 및 전문 병원 증가, 망막 영상 기술의 발전, 망막장애에 대한 인식 개선 등이 주요 요인으로 꼽힙니다.

망막장애 치료 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 212억 7,000만 달러에 이르고, CAGR은 9.4%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 지속형 망막 치료제 개발, 신규 생물학적 제제 및 유전자 치료제 승인 증가, 신흥 시장에서의 안과 의료 접근성 확대, 안과 연구개발 투자 증가, 개인 맞춤형 망막 치료 수요 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 항VEGF 요법의 도입 확대, 최소침습 망막수술로의 전환, 지속형 제제의 선호도 증가, 병용요법 접근법 확대, 재택 시력 모니터링 도구의 사용 증가 등을 들 수 있습니다.

당뇨병 유병률 증가는 향후 몇 년 동안 망막질환 치료제 시장의 성장을 견인할 것으로 예측됩니다. 당뇨병은 체내에서 충분한 인슐린을 생산하지 못하거나 인슐린을 효과적으로 이용하지 못해 혈당이 상승하는 만성질환입니다. 당뇨망막병증은 당뇨병 환자에서 가장 흔한 망막질환으로 망막혈관의 손상으로 인해 출혈, 삼출액 누출, 비정상적인 혈관 신생이 발생합니다. 망막장애의 치료에서 레이저는 새어 나오는 혈관을 막거나 비정상적인 혈관을 제거하기 위해 자주 사용됩니다. 예를 들어, 2024년 6월 영국 정부 기관인 국민보건서비스(NHS)는 2023년 영국에서 54만 9,000명 이상이 2형 당뇨병 발병 위험이 있는 것으로 확인되었고, 주치의에 등록된 비당뇨병성 고혈당(전당뇨병) 환자 수는 2022년 306만 5, 825명에서 361만 5,330명으로 증가하였습니다고 밝혔습니다. 825명에서 361만 5,330명으로 증가했습니다. 이처럼 당뇨병 유병률이 높아지면서 망막질환 치료에 대한 수요가 증가하고 있습니다.

망막질환 치료제 시장의 주요 기업들은 고객 기반 확대, 매출 증대, 수익 개선을 위해 지리적 위축증 치료와 같은 혁신적인 치료법에 집중하고 있습니다. 지리적 위축증 치료는 증상 관리, 질병 진행 지연, 시각 장애를 겪는 환자들을 돕는 것을 목표로 합니다. 예를 들어, 2023년 8월 일본 제약사 아스텔라스제약은 보체 C5 억제제 'IZERVAY'의 FDA 승인을 발표했습니다. 보체 C5 억제제인 IZERVAY는 2건의 임상 3상 시험에서 12개월 시점에서 주요 평가변수인 지리적 위축(GA) 진행을 통계적으로 유의하게 억제(p<:0.01)한 최초의 승인된 치료제로서, 노인황반변성(AMD)에 동반된 GA의 효과적인 치료제로서의 지위를 확립했습니다. 을 확립하였습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Retinal disorder treatment refers to medical interventions and procedures aimed at managing or improving symptoms associated with retinal disorders. These disorders involve abnormalities or damage to the retina, the light-sensitive tissue at the back of the eye responsible for transmitting visual signals to the brain.

The main types of retinal disorder treatments include macular degeneration, diabetic retinopathy, and others. Macular degeneration, often called age-related macular degeneration (AMD), is a chronic eye condition that primarily affects the macula, the central part of the retina responsible for sharp central vision. Treatments are available in various dosage forms, including gels, eye solutions, capsules, tablets, eye drops, and ointments, and are distributed through hospital pharmacies, online pharmacies, and retail pharmacies.

Tariffs have created notable challenges for the retinal disorder treatment market by increasing costs associated with importing active pharmaceutical ingredients, biologics, medical devices, and ophthalmic diagnostic equipment. These cost pressures have impacted drug manufacturing and distribution, particularly affecting injectable therapies, advanced dosage forms, and hospital pharmacy channels. Regions heavily dependent on imports, such as parts of Asia-Pacific, Latin America, and emerging Middle Eastern markets, are most affected by tariff-related supply chain disruptions. However, tariffs have also encouraged local manufacturing, regional sourcing of raw materials, and strategic partnerships, supporting long-term supply resilience and localized production capabilities.

The retinal disorder treatment market research report is one of a series of new reports from The Business Research Company that provides retinal disorder treatment market statistics, including retinal disorder treatment industry global market size, regional shares, competitors with a retinal disorder treatment market share, detailed retinal disorder treatment market segments, market trends and opportunities, and any further data you may need to thrive in the retinal disorder treatment industry. This retinal disorder treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The retinal disorder treatment market size has grown strongly in recent years. It will grow from $13.69 billion in 2025 to $14.86 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rising prevalence of age-related macular degeneration, increasing diabetic population globally, growth in ophthalmology clinics and specialty hospitals, advancements in retinal imaging technologies, improved awareness of retinal diseases.

The retinal disorder treatment market size is expected to see strong growth in the next few years. It will grow to $21.27 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to development of long-acting retinal drugs, increasing approval of novel biologics and gene therapies, expanding access to eye care in emerging markets, rising investment in ophthalmic research, growing demand for personalized retinal treatments. Major trends in the forecast period include growing adoption of anti-VEGF therapies, shift toward minimally invasive retinal procedures, increasing preference for sustained-release drug formulations, expansion of combination therapy approaches, rising use of home-based vision monitoring tools.

The rising prevalence of diabetes is expected to drive growth in the retinal disorder treatment market in the coming years. Diabetes is a chronic condition characterized by elevated blood glucose levels, caused by the body's inability to produce enough insulin or use it effectively. Diabetic retinopathy, the most common retinal disorder among diabetic patients, results from damage to retinal blood vessels, leading to bleeding, fluid leakage, and abnormal blood vessel growth. Retinal disorder treatments often use lasers to seal leaking vessels or eliminate abnormal ones. For example, in June 2024, the National Health Service (NHS), a UK-based government department, reported that in 2023, over 549,000 additional individuals in England were identified at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330, up from 3,065,825 in 2022. The growing prevalence of diabetes is therefore boosting demand for retinal disorder treatments.

Key players in the retinal disorder treatment market are focusing on innovative therapies, such as treatments for geographic atrophy, to expand their customer base, increase sales, and enhance revenue. Geographic atrophy therapies aim to manage symptoms, slow disease progression, and support patients coping with visual impairment. For instance, in August 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, announced FDA approval for IZERVAY. IZERVAY, a complement C5 inhibitor, is the first approved therapy for geographic atrophy (GA) to show a statistically significant reduction (p<0.01) in GA progression at the 12-month primary endpoint in two Phase 3 trials, establishing it as an effective treatment for GA secondary to age-related macular degeneration (AMD).

In July 2023, Astellas Pharma Inc. acquired Iveric Bio Inc., a US-based biopharmaceutical company specializing in retinal disease therapies, for an undisclosed amount. This acquisition enables Astellas to strengthen its presence in ophthalmology, access innovative treatments for retinal disorders, and reinforce its position in the market for vision-related therapies.

Major companies operating in the retinal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Regeneron Pharmaceuticals Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Apellis Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Adverum Biotechnologies Inc., Kodiak Sciences Inc., Acucela Inc., IVERIC bio Inc., Oxurion NV, Graybug Vision Inc., Clearside Biomedical Inc., Ophthotech Corporation, Opthea Limited, PanOptica Inc., ThromboGenics NV

North America was the largest region in the retinal disorder treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal disorder treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the retinal disorder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The retinal disorder treatment market includes revenues earned by entities by providing retinal detachment, laser treatment, genetic treatments, and photodynamic therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Retinal Disorder Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses retinal disorder treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for retinal disorder treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The retinal disorder treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Macular Degeneration; Diabetic Retinopathy; Other Types
• 2) By Dosage Form: Gels; Eye Solutions; Capsules And Tablets; Eye Drops; Ointments
• 3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• Subsegments:
• 1) By Macular Degeneration: Dry Macular Degeneration; Wet Macular Degeneration
• 2) By Diabetic Retinopathy: Non-Proliferative Diabetic Retinopathy; Proliferative Diabetic Retinopathy
• 3) By Other Types: Retinal Detachment; Retinitis Pigmentosa; Uveitis; Other Retinal Disorders
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG; Novartis AG; Regeneron Pharmaceuticals Inc.; Genentech Inc.; Santen Pharmaceutical Co. Ltd.; Apellis Pharmaceuticals Inc.; Alimera Sciences Inc.; Ocular Therapeutix Inc.; EyePoint Pharmaceuticals Inc.; Adverum Biotechnologies Inc.; Kodiak Sciences Inc.; Acucela Inc.; IVERIC bio Inc.; Oxurion NV; Graybug Vision Inc.; Clearside Biomedical Inc.; Ophthotech Corporation; Opthea Limited; PanOptica Inc.; ThromboGenics NV
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Retinal Disorder Treatment Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Retinal Disorder Treatment Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Retinal Disorder Treatment Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Retinal Disorder Treatment Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Growing Adoption Of Anti-VEGF Therapies
  • 4.2.2 Shift Toward Minimally Invasive Retinal Procedures
  • 4.2.3 Increasing Preference For Sustained-Release Drug Formulations
  • 4.2.4 Expansion Of Combination Therapy Approaches
  • 4.2.5 Rising Use Of Home-Based Vision Monitoring Tools

5. Retinal Disorder Treatment Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Ophthalmology Clinics
• 5.3 Ambulatory Surgical Centers
• 5.4 Academic And Research Institutes
• 5.5 Homecare Settings

6. Retinal Disorder Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Retinal Disorder Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Retinal Disorder Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Retinal Disorder Treatment Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Retinal Disorder Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Retinal Disorder Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Retinal Disorder Treatment Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Retinal Disorder Treatment Market Segmentation

• 9.1. Global Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Macular Degeneration, Diabetic Retinopathy, Other Types
• 9.2. Global Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments
• 9.3. Global Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
• 9.4. Global Retinal Disorder Treatment Market, Sub-Segmentation Of Macular Degeneration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Dry Macular Degeneration, Wet Macular Degeneration
• 9.5. Global Retinal Disorder Treatment Market, Sub-Segmentation Of Diabetic Retinopathy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy
• 9.6. Global Retinal Disorder Treatment Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Retinal Detachment, Retinitis Pigmentosa, Uveitis, Other Retinal Disorders

10. Retinal Disorder Treatment Market Regional And Country Analysis

• 10.1. Global Retinal Disorder Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Retinal Disorder Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Retinal Disorder Treatment Market

• 11.1. Asia-Pacific Retinal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Retinal Disorder Treatment Market

• 12.1. China Retinal Disorder Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Retinal Disorder Treatment Market

• 13.1. India Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Retinal Disorder Treatment Market

• 14.1. Japan Retinal Disorder Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Retinal Disorder Treatment Market

• 15.1. Australia Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Retinal Disorder Treatment Market

• 16.1. Indonesia Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Retinal Disorder Treatment Market

• 17.1. South Korea Retinal Disorder Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Retinal Disorder Treatment Market

• 18.1. Taiwan Retinal Disorder Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Retinal Disorder Treatment Market

• 19.1. South East Asia Retinal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Retinal Disorder Treatment Market

• 20.1. Western Europe Retinal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Retinal Disorder Treatment Market

• 21.1. UK Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Retinal Disorder Treatment Market

• 22.1. Germany Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Retinal Disorder Treatment Market

• 23.1. France Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Retinal Disorder Treatment Market

• 24.1. Italy Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Retinal Disorder Treatment Market

• 25.1. Spain Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Retinal Disorder Treatment Market

• 26.1. Eastern Europe Retinal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Retinal Disorder Treatment Market

• 27.1. Russia Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Retinal Disorder Treatment Market

• 28.1. North America Retinal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Retinal Disorder Treatment Market

• 29.1. USA Retinal Disorder Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Retinal Disorder Treatment Market

• 30.1. Canada Retinal Disorder Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Retinal Disorder Treatment Market

• 31.1. South America Retinal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Retinal Disorder Treatment Market

• 32.1. Brazil Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Retinal Disorder Treatment Market

• 33.1. Middle East Retinal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Retinal Disorder Treatment Market

• 34.1. Africa Retinal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Retinal Disorder Treatment Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Retinal Disorder Treatment Market Regulatory and Investment Landscape

36. Retinal Disorder Treatment Market Competitive Landscape And Company Profiles

• 36.1. Retinal Disorder Treatment Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Retinal Disorder Treatment Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Retinal Disorder Treatment Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Retinal Disorder Treatment Market Other Major And Innovative Companies

• Regeneron Pharmaceuticals Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Apellis Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Adverum Biotechnologies Inc., Kodiak Sciences Inc., Acucela Inc., IVERIC bio Inc., Oxurion NV, Graybug Vision Inc., Clearside Biomedical Inc., Ophthotech Corporation

38. Global Retinal Disorder Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Retinal Disorder Treatment Market

40. Retinal Disorder Treatment Market High Potential Countries, Segments and Strategies

• 40.1 Retinal Disorder Treatment Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Retinal Disorder Treatment Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Retinal Disorder Treatment Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer